Komori
Ushio (6925) · RiskRestated

Risks related to fixed-asset impairment and recoverability of deferred tax assets amid prolonged COVID-19

First written in FY2021. 7 of 9 entries say "Restated". Latest entry: FY2024-Q1.

9entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021 – FY2023-Q32021: 320212022: 320222023: 32023
Same theme, other companies
Complex estimate risk involving fixed-asset impairment and the recoverability of deferred tax assetsA theme 3 companies write about · 3 as a headwind · 0 as a tailwind

1 other company's latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2024-Q1RestatedAnnual report

    「There has been no material change in the assumptions used for accounting estimates related to the impact of COVID-19 and the Russia-Ukraine situation from the disclosures under "Significant Accounting Estimates" in the annual securities report for the previous consolidated fiscal year.」

    The Company reconfirmed that there had been no material change from the previous fiscal year in accounting estimates related to impairment of fixed assets, deferred tax assets and other items due to prolonged COVID-19.
  2. FY2023MitigatedAnnual report

    「Cinema reopenings and the recovery of operations are progressing mainly in Europe and North America, and the impact of the spread of COVID-19 itself is expected to diminish going forward.」

    Although accounting estimation risks based on prolonged COVID-19 remain, the assumption has changed to reflect an expected decline in the impact as the visual imaging market recovers.
  3. FY2023-Q3RestatedAnnual report

    「There has been no material change in the assumptions used for accounting estimates related to the impact of COVID-19 from the disclosures under "Significant Accounting Estimates" in the annual securities report for the previous consolidated fiscal year.」

    The Company reconfirmed that there had been no material change from the previous fiscal year in accounting estimates related to impairment of fixed assets, deferred tax assets and other items in connection with the impact of COVID-19.
  4. FY2023-Q2RestatedAnnual report

    「There has been no material change in the assumptions used for accounting estimates related to the impact of COVID-19 from the disclosures under "Significant Accounting Estimates" in the annual securities report for the previous consolidated fiscal year.」

    The Company reconfirmed that there had been no material change from the previous fiscal year in accounting estimates related to impairment of fixed assets, deferred tax assets and other items in connection with the impact of COVID-19.
  5. FY2023-Q1RestatedAnnual report

    「There has been no material change in the assumptions used for accounting estimates related to the impact of COVID-19 from the disclosures under "Significant Accounting Estimates" in the annual securities report for the previous consolidated fiscal year.」

    The Company reconfirmed that there had been no material change from the previous fiscal year in accounting estimates related to impairment of fixed assets, deferred tax assets and other items in connection with the impact of COVID-19.
  6. FY2022-Q3RestatedAnnual report

    「The Group has made accounting estimates for impairment of fixed assets and the recoverability of deferred tax assets, assuming that these conditions would remain to a certain extent in the fiscal year ending March 2022. There has been no material change in the assumptions used for these accounting estimates from the previous consolidated fiscal year.」

    The assumption that the impact of COVID-19 would remain to a certain extent in the fiscal year ending March 2022 was maintained and used in estimating impairment of fixed assets and the recoverability of deferred tax assets.
  7. FY2022-Q2RestatedAnnual report

    「The Group has made accounting estimates for impairment of fixed assets and the recoverability of deferred tax assets, assuming that these conditions would remain to a certain extent in the fiscal year ending March 2022. There has been no material change in the assumptions used for these accounting estimates from the previous consolidated fiscal year.」

    The assumption that the impact of COVID-19 would remain to a certain extent in the fiscal year ending March 2022 was maintained and used in estimating impairment of fixed assets and the recoverability of deferred tax assets.
  8. FY2022-Q1RestatedAnnual report

    「The Group has made accounting estimates for impairment of fixed assets and the recoverability of deferred tax assets, assuming that these conditions would remain to a certain extent in the fiscal year ending March 2022. There has been no material change in the assumptions used for these accounting estimates from the previous consolidated fiscal year.」

    The assumption that the impact of COVID-19 would remain to a certain extent in the fiscal year ending March 2022 was maintained and used in estimating impairment of fixed assets and the recoverability of deferred tax assets.
  9. FY2021First statedAnnual report

    「If future events diverge from the assumptions in (2) above, such as a further delay in the expected timing of containment of COVID-19, an unanticipated decline in selling prices or a decrease in sales volume, the Company may recognize an impairment loss on fixed assets in the next consolidated fiscal year.」

    The Company considered indicators of impairment for fixed assets in the Light Sources and Visual Imaging businesses but recognized no impairment loss, while disclosing the future risk of impairment due to prolonged COVID-19 and deviations in selling prices and volumes.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Ushio's next results are scheduled for 2026-11-06. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.